Insider Selling: Oscar Health (NYSE:OSCR) Insider Sells 286,182 Shares of Stock

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) insider Mario Schlosser sold 286,182 shares of Oscar Health stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $15.27, for a total value of $4,369,999.14. Following the completion of the sale, the insider owned 501,148 shares in the company, valued at $7,652,529.96. This represents a 36.35% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

• 5 Small Cap Stocks With Explosive Upside Potential

Mario Schlosser also recently made the following trade(s):

• On Monday, September 22nd, Mario Schlosser sold 395,000 shares of Oscar Health stock. The stock was sold at an average price of $18.43, for a total value of $7,279,850.00.

Oscar Health Stock Down 4.2%

Shares of OSCR opened at $14.09 on Thursday. The company's 50-day moving average price is $18.51 and its 200 day moving average price is $16.91. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.80. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67. The firm has a market cap of $3.73 billion, a P/E ratio of -12.58 and a beta of 1.88.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share for the quarter, topping the consensus estimate of ($0.55) by $0.02. The company had revenue of $2.93 billion during the quarter, compared to analyst estimates of $3.09 billion. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. Oscar Health's revenue was up 23.2% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.22) earnings per share. Oscar Health has set its FY 2025 guidance at EPS. On average, sell-side analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Institutional Investors Weigh In On Oscar Health

A number of hedge funds have recently bought and sold shares of OSCR. Vanguard Group Inc. grew its position in shares of Oscar Health by 2.1% during the third quarter. Vanguard Group Inc. now owns 20,160,399 shares of the company's stock worth $381,636,000 after buying an additional 423,184 shares in the last quarter. T. Rowe Price Investment Management Inc. lifted its stake in Oscar Health by 4.1% in the first quarter. T. Rowe Price Investment Management Inc. now owns 11,826,245 shares of the company's stock worth $155,043,000 after acquiring an additional 467,301 shares during the last quarter. Thrive Capital Management LLC lifted its stake in Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after acquiring an additional 1,588,395 shares during the last quarter. American Century Companies Inc. grew its holdings in Oscar Health by 89.0% during the 3rd quarter. American Century Companies Inc. now owns 5,298,340 shares of the company's stock worth $100,298,000 after acquiring an additional 2,495,691 shares in the last quarter. Finally, BIT Capital GmbH increased its position in shares of Oscar Health by 1.1% in the 1st quarter. BIT Capital GmbH now owns 4,521,445 shares of the company's stock valued at $59,276,000 after purchasing an additional 47,592 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the company. Wells Fargo & Company decreased their price target on Oscar Health from $14.00 to $11.00 and set an "underweight" rating on the stock in a research note on Thursday, November 13th. Zacks Research upgraded Oscar Health from a "strong sell" rating to a "hold" rating in a report on Monday, October 13th. Piper Sandler dropped their target price on Oscar Health from $14.00 to $13.00 and set a "neutral" rating for the company in a research report on Thursday, August 14th. UBS Group increased their price target on shares of Oscar Health from $11.00 to $12.00 and gave the stock a "sell" rating in a research report on Friday, November 7th. Finally, Weiss Ratings reissued a "sell (d)" rating on shares of Oscar Health in a research note on Wednesday, October 8th. Six investment analysts have rated the stock with a Hold rating and five have given a Sell rating to the stock. Based on data from MarketBeat, Oscar Health presently has an average rating of "Reduce" and an average target price of $13.14.

View Our Latest Analysis on Oscar Health

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Featured Stories

• Five stocks we like better than Oscar Health
• Profitably Trade Stocks at 52-Week Highs
• onsemi Places a $6 Billion Bet on Its Own Stock
• How to Use the MarketBeat Dividend Calculator
• HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?
• The Significance of Brokerage Rankings in Stock Selection
• End the Year Strong With These 3 Comeback Champions

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Oscar Health Right Now?

Before you consider Oscar Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.

While Oscar Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here